Max Planck Institute for Biophysical Chemistry

This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (February 2013) (Learn how and when to remove this template message)

Max Planck Institute
for Biophysical Chemistry
(Karl-Friedrich Bonhoeffer Institute)

Max-Planck-Institut für biophysikalische Chemie (Karl-Friedrich-Bonhoeffer-Institut)
Aerial photograph of the institute
Predecessor	MPI for Physical Chemistry MPI for Spectroscopy
Successor	Max Planck Institute for Multidisciplinary Sciences
Formation	1971; 53 years ago (1971)
Type	Scientific institute
Legal status	Merged with the Max Planck Institute for Experimental Medicine
Purpose	Research in biophysical chemistry
Headquarters	Göttingen, Lower Saxony, Germany
Parent organization	Max Planck Society

The Max Planck Institute for Biophysical Chemistry (German: Max-Planck-Institut für biophysikalische Chemie), also known as the Karl-Friedrich Bonhoeffer Institute (German: Karl-Friedrich-Bonhoeffer-Institut), was a research institute of the Max Planck Society, located in Göttingen, Germany. On January 1, 2022, the institute merged with the Max Planck Institute for Experimental Medicine in Göttingen to form the Max Planck Institute for Multidisciplinary Sciences.^[1]

This was the only Max Planck Institute (MPI) that combined the three classical scientific disciplines – biology, physics and chemistry. Founded in 1971, its initial focus was on problems in physics in chemistry. It had undergone a continuous evolution manifested through an expanding range of core subjects and work areas such as neurobiology, biochemistry, and molecular biology. At the time of merger, 850 people worked at the institute, about half of them scientists. Four researchers working at the institute – Stefan Hell, 2014; Erwin Neher and Bert Sakmann, 1991; and Manfred Eigen, 1967 – were awarded the Nobel Prize.